Torrent Group Enters Diagnostics: Launches India’s Largest Reference Lab in Navi Mumbai

Ahmedabad-based Torrent Group is expanding its healthcare portfolio with a significant investment in India’s diagnostics sector. The company has launched Torrent Diagnostics, anchored by what it claims is the country’s largest national reference laboratory, signaling a focus on advanced medical testing.

A New Player in India’s Diagnostics Landscape

Torrent Diagnostics began operations with a 100,000 sq ft reference laboratory located in Navi Mumbai. This facility is equipped to perform over 3,500 tests across 15 diagnostic disciplines, ranging from routine pathology to highly specialized areas like molecular diagnostics, genomics, and transplant-related testing. The lab boasts advanced technology, including next-generation sequencing, MALDI-TOF systems, BSL-3 containment laboratories, and a transmission electron microscope – capabilities described as scarce in many Indian diagnostics facilities.

Did You Know? Torrent Diagnostics’ new laboratory supports more than 3,500 tests across 15 different diagnostic disciplines.

Torrent’s strategy centres on serving hospitals, clinicians, and smaller laboratories by providing outsourced complex testing services. This approach responds to a growing trend within the healthcare industry, where providers are prioritizing precision diagnostics, quicker turnaround times, and enhanced quality control.

Long-Term Vision and Strategic Positioning

Varun Mehta, a director at Torrent Group, stated the company views diagnostics as a long-term healthcare business built on scientific rigor, strong governance, and consistent performance. The reference lab structure is intended to facilitate scalability without compromising quality or clinical relevance. Torrent Diagnostics also plans to develop patient-facing services, including collection centres, trained staff, and user-friendly digital interfaces.

Expert Insight: By focusing on a centralized reference lab and specialized testing, Torrent Group appears to be positioning itself to capture a segment of the diagnostics market that demands high accuracy and complex analysis, rather than competing directly on price for routine tests. This suggests a deliberate strategy to build a reputation for quality and reliability.

Torrent’s entry into the diagnostics market coincides with a period of consolidation within the industry. While routine testing faces pricing pressures, specialized diagnostics offer stronger growth potential and higher margins. The company has not disclosed specific investment details or expansion timelines, but its emphasis on advanced infrastructure suggests a measured rollout.

This move represents a strategic expansion for Torrent Group, which already has established businesses in pharmaceuticals, power, and gas. Mumbai-based Lupin entered the diagnostics space in 2021 with the launch of Lupin Diagnostics, also establishing a reference laboratory in Navi Mumbai.

Analysts note that the diagnostics sector is attracting new entrants due to low barriers to entry, high returns on capital employed (over 50 percent), and rapid growth. The increasing trend of pharmaceutical companies expanding into diagnostics is seen as a logical step, leveraging existing relationships with physicians.

India’s diagnostics sector, currently valued at Rs 55,000-crore, remains largely fragmented. Analysts predict the share of organised players will increase from 15 percent to 25 percent within the next three to five years. A growing trend towards ‘wellness’ testing and preventive healthcare is also emerging, particularly with the rise of online diagnostics platforms.

Frequently Asked Questions

What type of testing will Torrent Diagnostics offer?

Torrent Diagnostics will offer over 3,500 tests across 15 diagnostic disciplines, including preventive and routine pathology, molecular diagnostics, genomics, transplant-related testing, and infectious disease workflows.

Where is Torrent Diagnostics’ primary laboratory located?

Torrent Diagnostics’ primary reference laboratory is located in Navi Mumbai and spans 100,000 sq ft.

What is driving the growth of the diagnostics sector in India?

Analysts feel low entry barriers, high return on capital employed, fast growth, and a trend of pharma companies expanding into diagnostics are attracting new entrants to the sector.

As healthcare providers increasingly focus on precision diagnostics and outsourcing complex testing, how might this shift impact the overall quality and accessibility of medical services in India?